Hanmis obesity and diabetes treatment portfolio has the product strength to address these needs. He added, Through this partnership, we aim to contribute to addressing obesity and diabetes, which are rising rapidly in Mexico. Hanmi Pharmaceutical CEO Park Jae-hyun said, This agreement is a meaningful milestone that highlights Hanmis formulation technology and R&D competitiveness on the global stage
The 50/25/25 Rule (Vegetables, Protein, Starches) One way to manage GLP-1 side effects is by following the 50/25/25 rule when building your plate
No deals
Contact Person: Jitender Mishra Company: Lucknow Speciality Pharma Address: 2nd Floor, 207-A, Felix Square, Golf City, Gomti Nagar, Lucknow, Uttar Pradesh 226030 Phone: 9336559090, 9760014849 WhatsApp: 9336559090, 9760014849 Email: [email protected] Note: Lucknow Speciality Pharma are an authorized distributor and facilitate access to licensed Zydus pharmaceutical products